Tag Archives: Healthcare

I will never forgive Donald Trump for saying something exceedingly controversial with which I agree. I hate to say this but I agree with Trump and disagree with Fauci on hydroxychloroquine and Remdesivir. Update: But don’t mix the Hydroxychloroquine with Azithromycin“Azithromycin: (Major) Avoid coadministration of hydroxychloroquine and azithromycin.” Thanks Ted Lieu I will discuss hydroxychloroquine here because there is no legal issue. It can be...

I am sure by now many of you have read what the gov is and is not doing for us. The later is more prevalent as can be witnessed in the stimuli being offered. I am going to ask you to pay attention to the last item on ACA Healthcare Insurance. Whether you qualified or not in the past, you may be eligible for assistance now. I have broken this out into 4-points of which many of us might find ourselves. If you questions, PLEASE ASK, I will try to answer. The...

It is a start, maybe. Remdesivir is being touted as a potentially more effective drug. The Chinese had reported there were several pharmaceuticals which appeared to work also and in particular drugs for malaria, Chloroquine and HydoxyChloroquine. I had mentioned this earlier in the week in a post and then again in two separate comments. One small clinical test (preliminary trial with 24 -36 patients) in France had positive results recently as reported...

We do not know how severe the covid-19 epidemic will be or how much economic and social pain it will cause, but it clearly has the potential to kill hundreds of thousands or even millions of Americans, and the economic consequences could include a deep recession and even a financial crisis that will cause misery to tens of millions of people. Testing is key to getting the epidemic under control, and it is not clear to me that policymakers are being nearly...

This is, in fact, another post on Coronavirus, but it will take me a while to get to the point. To put the conclusion here, I think that it is important to get the FDA out of the way (by executive order if necessary). The Food and Drug Act, as currently interpreted, requires the assumption that people should (generally) not be treated with pharmaceuticals which haven’t been proven to be safe and effective. The rule is first do no harm, second do no harm....

To Slow Spread Of Coronovirus, End Iran Sanctions On 3/13/20 in Foreign Policy Focus, Ariel Gold and Medea Benjamin argue that to improve the global coronavirus problem, sanctions on Iran should be lifted, quite aside from the fact they should never have been imposed in the first place as Iran was adhering to the JCPOA nuclear deal. The effect of the sanctions has been to tank the Iranian economy, including its health care sector, much worsening the...

The San Francisco Chronicle reports “shelter in place” restrictions.  My daughter lives in Santa Clara county, where schools are closed till April 13. Six Bay Area counties announced a “shelter in place” order for all residents on Monday — the strictest measure of its kind in the country — directing everyone to stay inside their homes and away from others as much as possible for the next three weeks as public health officials desperately try to curb the...

Welt am Sonntag is reporting our honorable President is attempting to bribe lure a German company CureVac to develop a vaccine  to be used only in the US. Germany’s Health Ministry confirmed a report in the newspaper “Welt am Sonntag”, which said President Donald Trump had offered bribes funds to lure the German company CureVac to the United States, and the German government was making counter-offers to tempt it to stay. Welt am Sonntag quoted an...

Europe’s Response to Coronavirus and the Implications for the U.S. As I listened to the morning news about the coronavirus crisis, I was reminded of this critique of the Eurozone: In a recent conference, the distinguished economist Paul Krugman repeated the oft-heard critique that the eurozone is not an optimal currency area. Waltraud Schelkle disagrees with this characterisation, and argues that no country or group of countries represents an optimal...

Benefit-Cost Analysis and the Coronavirus We are in the middle of a flurry of decision-making on how to deal with COVID-19.  After much resistance, officials are now canceling public events, closing schools and discouraging other activities that put us in contact with each other.  Travel restrictions and possible shutdowns of workplaces, as we’ve seen in Italy, may be up next. It’s interesting we haven’t heard anything about benefit-cost analysis in...